Association of Torquetenovirus Viremia with Physical Frailty and Cognitive Impairment in Three Independent European Cohorts

Introduction: Immunosenescence and inflammaging have been implicated in the pathophysiology of frailty. Torquetenovirus (TTV), a single-stranded DNA anellovirus, the major component of the human blood virome, shows an increased replication rate with advancing age. An elevated TTV viremia has been associated with an impaired immune function and an increased risk of mortality in the older population. The objective of this study was to analyze the relation between TTV viremia, physical frailty, and cognitive impairment. Methods: TTV viremia was measured in 1,131 nonfrail, 45 physically frail, and 113 cognitively impaired older adults recruited in the MARK-AGE study (overall mean age 64.7 ± 5.9 years), and then the results were checked in two other independent cohorts from Spain and Portugal, including 126 frail, 252 prefrail, and 141 nonfrail individuals (overall mean age: 77.5 ± 8.3 years). Results: TTV viremia ≥4log was associated with physical frailty (OR: 4.69; 95% CI: 2.06–10.67, p < 0.0001) and cognitive impairment (OR: 3.49, 95% CI: 2.14–5.69, p < 0.0001) in the MARK-AGE population. The association between TTV DNA load and frailty status was confirmed in the Spanish cohort, while a slight association with cognitive impairment was observed (OR: 1.33; 95% CI: 1.000–1.773), only in the unadjusted model. No association between TTV load and frailty or cognitive impairment was found in the Portuguese sample, although a negative association between TTV viremia and MMSE score was observed in Spanish and Portuguese females. Conclusions: These findings demonstrate an association between TTV viremia and physical frailty, while the association with cognitive impairment was observed only in the younger population from the MARK-AGE study. Further research is necessary to clarify TTV’s clinical relevance in the onset and progression of frailty and cognitive decline in older individuals.

[1]  G. Pawelec,et al.  Cellular immune phenotypes and worsening scores of frailty-associated parameters over an 18-month period in the very old. , 2021, The journals of gerontology. Series A, Biological sciences and medical sciences.

[2]  A. Larbi,et al.  Pathogenic load and frailty in older adults: Singapore longitudinal ageing study , 2020, Aging.

[3]  S. Bonassi,et al.  Association of inflammatory mediators with frailty status in older adults: results from a systematic review and meta-analysis , 2020, GeroScience.

[4]  F. Barbé-Tuana,et al.  The interplay between immunosenescence and age-related diseases , 2020, Seminars in Immunopathology.

[5]  J. Teixeira,et al.  Frailty syndrome, biomarkers and environmental factors - a pilot study. , 2020, Toxicology letters.

[6]  C. Franceschi,et al.  Prevalence and loads of torquetenovirus (TTV) in the European MARK-AGE Study population. , 2019, The journals of gerontology. Series A, Biological sciences and medical sciences.

[7]  G. Kobbe,et al.  The value of Torque Teno Virus (TTV) as a marker for the degree of immunosuppression in adult patients after hematopoietic stem cell transplantation (HSCT). , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8]  C. Franceschi,et al.  Antioxidants linked with physical, cognitive and psychological frailty: Analysis of candidate biomarkers and markers derived from the MARK-AGE study , 2019, Mechanisms of Ageing and Development.

[9]  J. Millán-Calenti,et al.  Exploring Genetic Outcomes as Frailty Biomarkers , 2019, The journals of gerontology. Series A, Biological sciences and medical sciences.

[10]  B. Gustafsson,et al.  Virome definition in cerebrospinal fluid of patients with neurological complications after hematopoietic stem cell transplantation. , 2018, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[11]  M. Pistello,et al.  Torquetenovirus (TTV) load is associated with mortality in Italian elderly subjects , 2018, Experimental Gerontology.

[12]  L. Berca,et al.  Prevalence of human anelloviruses in Romanian healthy subjects and patients with common pathologies , 2018, BMC Infectious Diseases.

[13]  S. Bonassi,et al.  Frailty Syndrome and Genomic Instability in Older Adults: Suitability of the Cytome Micronucleus Assay As a Diagnostic Tool , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

[14]  F. Panza,et al.  Emerging biomarkers and screening for cognitive frailty , 2017, Aging Clinical and Experimental Research.

[15]  G. Antonelli,et al.  Torquetenovirus: the human virome from bench to bedside. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  Tilman Grune,et al.  Mechanisms of Ageing and Development MARK-AGE standard operating procedures (SOPs): A successful effort , 2022 .

[17]  C. Franceschi,et al.  Quality control data of physiological and immunological biomarkers measured in serum and plasma , 2015, Mechanisms of Ageing and Development.

[18]  Marco Zoli,et al.  MARK-AGE population: From the human model to new insights , 2015, Mechanisms of Ageing and Development.

[19]  Tobias Kötter,et al.  The MARK-AGE phenotypic database: Structure and strategy , 2015, Mechanisms of Ageing and Development.

[20]  Bertrand Friguet,et al.  Mechanisms of Ageing and Development Mark-age Biomarkers of Ageing , 2022 .

[21]  A. Mitnitski,et al.  Standard laboratory tests to identify older adults at increased risk of death , 2014, BMC Medicine.

[22]  E. Puchhammer-Stöckl,et al.  TTV DNA plasma load and its association with age, gender, and HCMV IgG serostatus in healthy adults , 2014, AGE.

[23]  C. Franceschi,et al.  Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[24]  C. Bonorino,et al.  The Inverted CD4:CD8 Ratio Is Associated with Cytomegalovirus, Poor Cognitive and Functional States in Older Adults , 2014, Neuroimmunomodulation.

[25]  J. Morley,et al.  Frailty and cognition: Linking two common syndromes in older persons , 2013, The journal of nutrition, health & aging.

[26]  G. Savva,et al.  Frailty and cognitive impairment—A review of the evidence and causal mechanisms , 2013, Ageing Research Reviews.

[27]  Peter N. Murakami,et al.  American Journal of Epidemiology Original Contribution Cytomegalovirus Infection and the Risk of Mortality and Frailty in Older Women: a Prospective Observational Cohort Study , 2022 .

[28]  M. Guerreiro,et al.  Cut‐off scores in MMSE: a moving target? , 2010, European journal of neurology.

[29]  M. Pistello,et al.  Torquetenovirus DNA drives proinflammatory cytokines production and secretion by immune cells via toll-like receptor 9. , 2009, Virology.

[30]  P. Barberger‐Gateau,et al.  Seropositivity to Herpes Simplex Virus Antibodies and Risk of Alzheimer's Disease: A Population-Based Cohort Study , 2008, PloS one.

[31]  A. Boner,et al.  Associations between nasal torquetenovirus load and spirometric indices in children with asthma. , 2005, The Journal of infectious diseases.

[32]  M. Pistello,et al.  Relationships between Total Plasma Load of Torquetenovirus (TTV) and TTV Genogroups Carried , 2005, Journal of Clinical Microbiology.

[33]  G. Pawelec,et al.  An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[34]  Yaniv Ziv,et al.  T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[35]  T. Strandberg,et al.  Impact of viral and bacterial burden on cognitive impairment in elderly persons with cardiovascular diseases. , 2003, Stroke.

[36]  M. Aguilar,et al.  Clinical validity of the ‘mini-mental state’ for Spanish speaking communities , 2001, Neuropsychologia.

[37]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[38]  T. Nishizawa,et al.  Circular Double-Stranded Forms of TT Virus DNA in the Liver , 2000, Journal of Virology.

[39]  P. Schnitzler,et al.  TT Virus as a Human Pathogen: Significance and Problems , 2004, Virus Genes.